No Picture
News

Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5

SAN DIEGO, Sept. 23, 2020 /PRNewswire/ — Neurelis, Inc., announced today that it will be investigating the safety and pharmacokinetics of the company’s lead product, VALTOCO® (diazepam nasal spray), in children with epilepsy aged two to five. VALTO… […]

No Picture
News

Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5

SAN DIEGO, Sept. 23, 2020 /PRNewswire/ — Neurelis, Inc., announced today that it will be investigating the safety and pharmacokinetics of the company’s lead product, VALTOCO® (diazepam nasal spray), in children with epilepsy aged two to five. VALTO… […]